Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt Medical ...

Boston Scientific Corporation has entered a definitive agreement to acquire the remaining 74% stake not yet owned in Bolt Medical, in a deal valued at up to $664m. The acquisition includes nearly ...

Boston Scientific will face more benign competition than previously feared when it comes to pulsed field ablation, according ...

Boston Scientific announced via social media that it has closed the acquisition of Bolt Medical, which recently gained FDA ...

Needham upgraded Boston Scientific (BSX) to Buy from Hold with a $113 price target Needham’s latest electrophysiologist survey shows the ...

Boston Scientific Corp.’s up to $664 million acquisition of Bolt Medical Inc. closed just days after Bolt secured U.S. FDA 520(k) clearance for its intravascular lithotripsy (IVL) system, positioning ...

Recent acquisitions are also seen as adding to Boston Scientific’s growth story. Bolt Medical’s new device for treating ...

Boston Scientific’s $664m bet on Bolt Medical has paid off, as the company’s intravascular lithotripsy (IVL) system gains US Food and Drug Administration (FDA) clearance. Whilst neither Bolt ...